Literature DB >> 21715326

Phage display of tissue inhibitor of metalloproteinases-2 (TIMP-2): identification of selective inhibitors of collagenase-1 (metalloproteinase 1 (MMP-1)).

Harinath Bahudhanapati1, Yingnan Zhang, Sachdev S Sidhu, Keith Brew.   

Abstract

Tissue inhibitor of metalloproteinases-2 (TIMP-2) is a broad spectrum inhibitor of the matrix metalloproteinases (MMPs), which function in extracellular matrix catabolism. Here, phage display was used to identify variants of human TIMP-2 that are selective inhibitors of human MMP-1, a collagenase whose unregulated action is linked to cancer, arthritis, and fibrosis. Using hard randomization of residues 2, 4, 5, and 6 (L1) and soft randomization of residues 34-40 (L2) and 67-70 (L3), a library was generated containing 2 × 10(10) variants of TIMP-2. Five clones were isolated after five rounds of selection with MMP-1, using MMP-3 as a competitor. The enriched phages selectively bound MMP-1 relative to MMP-3 and contained mutations only in L1. The most selective variant (TM8) was used to generate a second library in which residues Cys(1)-Gln(9) were soft-randomized. Four additional clones, selected from this library, showed a similar affinity for MMP-1 as wild-type TIMP-2 but reduced affinity for MMP-3. Variants of the N-terminal domain of TIMP-2 (N-TIMP-2) with the sequences of the most selective clones were expressed and characterized for inhibitory activity against eight MMPs. All were effective inhibitors of MMP-1 with nanomolar K(i) values, but TM8, containing Ser(2) to Asp and Ser(4) to Ala substitutions, was the most selective having a nanomolar K(i) value for MMP-1 but no detectable inhibitory activity toward MMP-3 and MMP-14 up to 10 μM. This study suggests that phage display and selection with other MMPs may be an effective method for discovering tissue inhibitor of metalloproteinase variants that discriminate between specified MMPs as targets.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21715326      PMCID: PMC3173135          DOI: 10.1074/jbc.M111.253328

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Identifying specificity profiles for peptide recognition modules from phage-displayed peptide libraries.

Authors:  Raffi Tonikian; Yingnan Zhang; Charles Boone; Sachdev S Sidhu
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

Review 2.  Progress in matrix metalloproteinase research.

Authors:  Gillian Murphy; Hideaki Nagase
Journal:  Mol Aspects Med       Date:  2008-05-24

Review 3.  The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity.

Authors:  Keith Brew; Hideaki Nagase
Journal:  Biochim Biophys Acta       Date:  2010-01-15

4.  Characterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9. Differential rates for activation by stromelysin 1.

Authors:  M W Olson; M M Bernardo; M Pietila; D C Gervasi; M Toth; L P Kotra; I Massova; S Mobashery; R Fridman
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

5.  Crystal structure of the catalytic domain of matrix metalloproteinase-1 in complex with the inhibitory domain of tissue inhibitor of metalloproteinase-1.

Authors:  Shalini Iyer; Shuo Wei; Keith Brew; K Ravi Acharya
Journal:  J Biol Chem       Date:  2006-10-18       Impact factor: 5.157

6.  The intrinsic protein flexibility of endogenous protease inhibitor TIMP-1 controls its binding interface and affects its function.

Authors:  Moran Grossman; Dmitry Tworowski; Orly Dym; Meng-Huee Lee; Yaakov Levy; Gillian Murphy; Irit Sagi
Journal:  Biochemistry       Date:  2010-07-27       Impact factor: 3.162

7.  Entropy increases from different sources support the high-affinity binding of the N-terminal inhibitory domains of tissue inhibitors of metalloproteinases to the catalytic domains of matrix metalloproteinases-1 and -3.

Authors:  Ying Wu; Shuo Wei; Steven R Van Doren; Keith Brew
Journal:  J Biol Chem       Date:  2011-03-28       Impact factor: 5.157

8.  Inactivation of N-TIMP-1 by N-terminal acetylation when expressed in bacteria.

Authors:  Steven R Van Doren; Shuo Wei; Guanghua Gao; Beverly B DaGue; Mark O Palmier; Harinath Bahudhanapati; Keith Brew
Journal:  Biopolymers       Date:  2008-11       Impact factor: 2.505

9.  Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors.

Authors:  Asmaa B Hamze; Shuo Wei; Harinath Bahudhanapati; Smitha Kota; K Ravi Acharya; Keith Brew
Journal:  Protein Sci       Date:  2007-07-27       Impact factor: 6.725

10.  Crystal structure of an active form of human MMP-1.

Authors:  Shalini Iyer; Robert Visse; Hideaki Nagase; K Ravi Acharya
Journal:  J Mol Biol       Date:  2006-08-04       Impact factor: 5.469

View more
  19 in total

1.  Development of High Affinity and High Specificity Inhibitors of Matrix Metalloproteinase 14 through Computational Design and Directed Evolution.

Authors:  Valeria Arkadash; Gal Yosef; Jason Shirian; Itay Cohen; Yuval Horev; Moran Grossman; Irit Sagi; Evette S Radisky; Julia M Shifman; Niv Papo
Journal:  J Biol Chem       Date:  2017-01-13       Impact factor: 5.157

2.  Targeting the MMP-14/MMP-2/integrin αvβ3 axis with multispecific N-TIMP2-based antagonists for cancer therapy.

Authors:  Gal Yosef; Valeria Arkadash; Niv Papo
Journal:  J Biol Chem       Date:  2018-07-09       Impact factor: 5.157

3.  Matrix metalloproteinase-10 (MMP-10) interaction with tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2: binding studies and crystal structure.

Authors:  Jyotica Batra; Jessica Robinson; Alexei S Soares; Alan P Fields; Derek C Radisky; Evette S Radisky
Journal:  J Biol Chem       Date:  2012-03-16       Impact factor: 5.157

4.  Directed evolution of the metalloproteinase inhibitor TIMP-1 reveals that its N- and C-terminal domains cooperate in matrix metalloproteinase recognition.

Authors:  Maryam Raeeszadeh-Sarmazdeh; Kerrie A Greene; Banumathi Sankaran; Gregory P Downey; Derek C Radisky; Evette S Radisky
Journal:  J Biol Chem       Date:  2019-04-30       Impact factor: 5.157

5.  Quantitative mapping of binding specificity landscapes for homologous targets by using a high-throughput method.

Authors:  Lidan Aharon; Shay-Lee Aharoni; Evette S Radisky; Niv Papo
Journal:  Biochem J       Date:  2020-05-15       Impact factor: 3.857

6.  Thermodynamic Basis of Selectivity in the Interactions of Tissue Inhibitors of Metalloproteinases N-domains with Matrix Metalloproteinases-1, -3, and -14.

Authors:  Haiyin Zou; Ying Wu; Keith Brew
Journal:  J Biol Chem       Date:  2016-03-31       Impact factor: 5.157

7.  Converting a broad matrix metalloproteinase family inhibitor into a specific inhibitor of MMP-9 and MMP-14.

Authors:  Jason Shirian; Valeria Arkadash; Itay Cohen; Tamila Sapir; Evette S Radisky; Niv Papo; Julia M Shifman
Journal:  FEBS Lett       Date:  2018-03-12       Impact factor: 4.124

Review 8.  Matrix metalloproteinases as breast cancer drivers and therapeutic targets.

Authors:  Evette S Radisky; Derek C Radisky
Journal:  Front Biosci (Landmark Ed)       Date:  2015-06-01

9.  Matrix metalloproteinase-10/TIMP-2 structure and analyses define conserved core interactions and diverse exosite interactions in MMP/TIMP complexes.

Authors:  Jyotica Batra; Alexei S Soares; Christine Mehner; Evette S Radisky
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

10.  Peptide-based selective inhibitors of matrix metalloproteinase-mediated activities.

Authors:  Margaret W Ndinguri; Manishabrata Bhowmick; Dorota Tokmina-Roszyk; Trista K Robichaud; Gregg B Fields
Journal:  Molecules       Date:  2012-11-30       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.